Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01053 |
Prolactin Receptor Protein, Human, Recombinant (His)
hPRLrI,PRLR,MFAB,HPRL,prolactin receptor |
Human | HEK293 Cells |
Prolactin Receptor Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 26 kDa and the accession number is P16471-1. | |||
TMPK-00547 |
PRLR Protein, Cynomolgus, Recombinant (His)
Prolactin R,HPRL,MFAB,PRL-R |
Cynomolgus | HEK293 Cells |
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers. PRLR Protein, Cynomolgus, Recombinant (His) is expressed in HEK... | |||
TMPK-01375 |
PRLR Protein, Canine, Recombinant (hFc)
PRL-R,Prolactin R,MFAB,HPRL |
Canine | HEK293 Cells |
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers. PRLR Protein, Canine, Recombinant (hFc) is expressed in HEK293 ... |